CHAMPIONS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Gross in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Champions Oncology, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2012 to Q1 2024.
  • Champions Oncology, Inc. Deferred Tax Assets, Gross for the quarter ending April 30, 2024 was $18.1M, a 8.06% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $18.1M +$1.35M +8.06% Apr 30, 2024 10-K 2024-07-19
Q1 2023 $16.8M +$1.25M +8.09% Apr 30, 2023 10-K 2024-07-19
Q1 2022 $15.5M +$161K +1.05% Apr 30, 2022 10-K 2023-07-24
Q1 2021 $15.3M -$119K -0.77% Apr 30, 2021 10-K 2022-07-22
Q1 2020 $15.5M +$507K +3.39% Apr 30, 2020 10-K 2021-07-26
Q1 2019 $15M +$544K +3.78% Apr 30, 2019 10-K 2020-07-28
Q1 2018 $14.4M -$7.41M -34% Apr 30, 2018 10-K 2019-07-29
Q1 2017 $21.8M +$2.75M +14.4% Apr 30, 2017 10-K 2018-07-30
Q1 2016 $19.1M +$3.86M +25.4% Apr 30, 2016 10-K 2017-07-28
Q1 2015 $15.2M +$4.24M +38.7% Apr 30, 2015 10-K 2016-07-29
Q1 2014 $11M +$2.02M +22.6% Apr 30, 2014 10-K 2015-07-29
Q1 2013 $8.95M +$2.58M +40.4% Apr 30, 2013 10-K 2014-07-28
Q1 2012 $6.37M Apr 30, 2012 10-K 2013-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.